Metformin Treatment in Hyperglycemic Critically Ill Patients: Another Challenge on the Control of Adverse Outcomes
| Author | Yunes Panahi | en |
| Author | Mojtaba Mojtahedzadeh | en |
| Author | Nuria Zekeri | en |
| Author | Fatemeh Beiraghdar | en |
| Author | Mohammad-Reza Khajavi | en |
| Author | Arezo Ahmadi | en |
| Issued Date | 2011-10-31 | en |
| Abstract | New-onset hyperglycemia in patients admitted to intensive care units increases the risk of morbidity and mortality. Insulin resistance is frequently seen in the treatment of stress-induced hyperglycemia. Metformin, an oral anti-hyperglycemic agent, may introduce a new treatment protocol in critically ill patients with insulin-resistance hyperglycemia. | en |
| DOI | https://doi.org/10.22037/ijpr.2011.1015 | en |
| Keyword | Metformin | en |
| Keyword | Hyperglycemic | en |
| Keyword | Ill patients | en |
| Keyword | Insulin. | en |
| Publisher | Brieflands | en |
| Title | Metformin Treatment in Hyperglycemic Critically Ill Patients: Another Challenge on the Control of Adverse Outcomes | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-10-913.pdf
- Size:
- 608.16 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF